Open access · CC-BY
via OpenAlex
Senolytic elimination of senescent macrophages restores muscle stem cell function in severely dystrophic muscle
Lei Liu, Xianlin Yue, Zewei Sun, William S. Hambright, Qi Feng, Yan Cui, Johnny Huard, Paul D. Robbins, Zhihui Wang, Xiaodong Mu
Aging · 2022 · ▲ 52 citations
Abstract
The aging of the immune system, or immunosenescence, was recently verified to have a causal role in driving the aging of solid organs, while the senolytic elimination of senescent immune cells was found to effectively delay systemic aging. Our recent study also showed that immune cells in severely dystrophic muscles develop senescence(definition)-like phenotypes, including the increased expression of senescence-associated secretory phenotype (SASP) factors and senescence markers. Here we further investigated whether the specific clearance of senescent immune cells in dystrophic muscle may effectively improve the function of muscle stem cells and the phenotypes of dystrophic muscle. We observed increased percentage of senescent cells in macrophages from mdx/utro(−/−) mice (a murine model for muscular dystrophy disease, dystrophin−/−; utrophin−/−), while the treatment of mdx/utro(−/−) macrophages with senolytic drug fisetin resulted in reduced number of senescent cells. We administrated fisetin to mdx/utro(−/−) mice for 4 weeks, and observed obviously reduced number of senescent immune cells, restored number of muscle cells, and improve muscle phenotypes. In conclusion, our results reveal that senescent immune cells, such as macrophages, are greatly involved in the development of muscle dystrophy by impacting the function of muscle stem cells, and the senolytic ablation of these senescent cells with fisetin can be an effective therapeutic strategy for improving function of muscle stem cells and phenotypes of dystrophic muscles.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/aging.204275
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Liu, L., Yue, X., Sun, Z., Hambright, W.S., Feng, Q., Cui, Y., Huard, J., Robbins, P.D., Wang, Z., & Mu, X. (2022). Senolytic elimination of senescent macrophages restores muscle stem cell function in severely dystrophic muscle. <em>Aging</em>. https://doi.org/10.18632/aging.204275
Vancouver
Liu L, Yue X, Sun Z, Hambright WS, Feng Q, Cui Y, et al. Senolytic elimination of senescent macrophages restores muscle stem cell function in severely dystrophic muscle. Aging. 2022. doi:10.18632/aging.204275.
BibTeX
@article{lei2022Senoly,
title = {Senolytic elimination of senescent macrophages restores muscle stem cell function in severely dystrophic muscle},
author = {Lei Liu and Xianlin Yue and Zewei Sun and William S. Hambright and Qi Feng and Yan Cui and Johnny Huard and Paul D. Robbins and Zhihui Wang and Xiaodong Mu},
journal = {Aging},
year = {2022},
doi = {10.18632/aging.204275},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Death and Disease 2024
Open access · CC-BY
mtDNA release promotes cGAS-STING activation and accelerated aging of postmitotic muscle cells
Nature 2006
Preprint · OA
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
PubMed 2024
Preprint
[Inflammaging: the role of senescent cells in the pathogenesis of osteoarthritis.]
Journal of Translational Medicine 2026
Open access · CC-BY
Synergistic senolytic–regenerative therapy significantly extends healthspan and lifespan
Journal of translational medicine 2026
Open access · OA
Synergistic senolytic-regenerative therapy significantly extends healthspan and lifespan.
Journal of Cachexia Sarcopenia and Muscle 2022
Open access · CC-BY